36920 Federal Register / Vol. 63, No. 130 /Wednesday, July 8, 1998 / Notices

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) referenced

in the Introduction through the

Superintendent of Documents,

Government Printing Office,

Washington, D.C. 20402–9325,

telephone: (202) 512–1800.

Dated: July 1, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–18017 Filed 7–7–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention (CDC)

[Announcement 98043]

National Partnership for Human

Immunodeficiency; Virus (HIV)

Prevention; Notice of Availability of

Funds for Fiscal Year 1998

Amendment

A notice announcing the availability

of Fiscal Year 1998 funds for grants to

support National Partnerships for

Human Immunodeficiency Virus (HIV)

Prevention Program was published in

the Federal Register on June 3, 1998,

[Vol. 63 FR No. 106]. The notice is

amended as follows:

On page 30233, third column, under

‘‘Eligible Applicants’’, the first

paragraph, line 12 should read: ‘‘Taxexempt status is determined by the

Internal Revenue Service (IRS) Code,

Section 501(c). Tax-exempt status may

be proved by either providing a copy of

the pages from the IRS’ most recent list

of 501 (c) tax-exempt organizations or a

copy of the current IRS Determination

Letter.’’

On page 30238, second column, under

‘‘Submission and Deadline’’, the second

paragraph should read: ‘‘On or before

August 7, 1998, submit the application

to: Julia Valentine Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office,

Announcement 98043, Centers for

Disease Control and Prevention (CDC),

Room 300, 255 East Paces Ferry Road,

NE, M/S E15, Atlanta, GA 30305–2209.

All other information and

requirements of the notice remain the

same.

Dated: July 1, 1998.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 98–18015 Filed 7–7–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 98085]

Young People in Alternative Education

Settings: Preventing HIV and Other

Sexually Transmitted Diseases Notice

of Availability of Fiscal Year 1998

Funds; Amendment

A notice announcing the availability

of fiscal year (FY) 1998 funds for

cooperative agreements for the

prevention of human immunodeficiency

virus (HIV), and other sexually

transmitted diseases (STDs) among

young people in alternative educational

settings was published in the Federal

Register on June 24, 1998, [Vol. 63 FR

Number 121]. The notice is amended as

follows:

On page 34432, third column, under

‘‘Application Submission and

Deadline’’, the second paragraph should

read: ‘‘An original and two copies of the

application PHS Form 5161–1 (Revised

5/96, OMB Number 0937–0189) must be

submitted to Sharron P. Orum, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Room

300, Mail Stop E–18, 255 East Paces

Ferry Road, NE., Atlanta, GA 30305, on

or before August 15, 1998.’’

All other information and

requirements of the notice remain the

same.

Dated: July 01, 1998.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 98–18023 Filed 7–7–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committees; Filing of Annual

Reports

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that, as required by the Federal

Advisory Committee Act, the agency has

filed with the Library of Congress the

annual reports of those FDA advisory

committees that held closed meetings

during fiscal year 1995, 1996, and 1997.

FDA apologizes for the lateness in the

filing of these reports due to

circumstances beyond the agency’s

control.

ADDRESSES: Copies are available from

the Dockets Management Branch (HFA–

305), Food and Drug Administration,

5630 Fishers Lane, rm. 1061, Rockville,

MD 20852, 301–443–1751.

FOR FURTHER INFORMATION CONTACT:

Donna M. Combs, Committee

Management Office (HFA–306), Food

and Drug Administration, 5600 Fishers

Lane, Rockville, MD 20857, 301–827–

4820.

SUPPLEMENTARY INFORMATION: Under

section 13 of the Federal Advisory

Committee Act (5 U.S.C. app. 2) and 21

CFR 14.60(c), FDA has filed with the

Library of Congress the annual reports

for the following FDA advisory

committees that held closed meetings

during the period October 1, 1994,

through September 30, 1995:

Center for Biologics Evaluation and

Research:

Allergenic Products Advisory

Committee,

Biological Response Modifiers

Advisory Committee,

Blood Products Advisory Committee,

Vaccines and Related Biological

Products Advisory Committee.

Center for Drug Evaluation and

Research:

Anesthetic and Life Support Drugs

Advisory Committee,

Anti-Infective Drugs Advisory

Committee,

Antiviral Drugs Advisory Committee,

Arthritis Advisory Committee,

Drug Abuse Advisory Committee,

Endocrinologic and Metabolic Drugs

Advisory Committee,

Generic Drugs Advisory Committee,

Medical Imaging Drugs Advisory

Committee,

Nonprescription Drugs Advisory

Committee,

Oncologic Drugs Advisory Committee.

Center for Devices and Radiological

Health:

Medical Devices Advisory Committee

(consisting of reports for the

Anesthesiology and Respiratory

Therapy Devices Panel; Circulatory

System Devices Panel; Clinical

Chemistry and Clinical Toxicology